… Neuropsychiatric symptoms (NPS) are a risk factor for cognitive impairment and are … We
conducted a cross-sectional study derived from the ongoing population-based Mayo Clinic Study …

Introduction We examined the association between cerebrospinal fluid (CSF)‐derived
biomarkers of Alzheimer's disease and neuropsychiatric symptoms (NPS) in older non‐demented …

… Medical Education and Research, the Edli Foundation and Barrow Neurological Institute.
We would like to thank study coordinators and research nurses at Mayo Clinic Study of Aging …

… other large-scale studies in the field. Also, one of the limitations of the study was that we
were not able to examine the association of neuropsychiatric symptoms with regions of interest …

… We conducted a prospective cohort study derived from the Mayo Clinic Study of Aging, a
longitudinal, population-based study of cognitive aging and MCI in Olmsted County, MN. Details …

… We conducted a longitudinal study derived from the population-based Mayo Clinic Study of
… the Neuropsychiatric Inventory Questionnaire at baseline and underwent neuropsychological …

We examined the associations between baseline neuropsychiatric symptoms (NPS) and
longitudinal changes in functional performance among 5,394 non-demented individuals aged…

… clinical depression (indicated by BDI-II scores ≥13), clinical anxiety (indicated by BAI scores
≥10), and the presence of neuropsychiatric symptoms … some neuropsychiatric symptoms in …

… OBJECTIVE: To examine neuropsychiatric symptoms (NPS), … as predicted by baseline
neuropsychiatric symptoms(NPS) … older), enrolled in the Mayo Clinic Study of Aging for a median (…

Objective: To determine the incidence of dementia as predicted by baseline neuropsychiatric
symptoms in subjects with prevalent mild cognitive impairment (MCI). Design: Prospective …